Pharmasoft
Clinical trials sponsored by Pharmasoft, explained in plain language.
-
Can a drug combo sharpen thinking in chronic brain ischemia?
Disease control CompletedThis study tested a drug called Mexidol, given first as a shot and then as a pill, in 318 adults aged 40-90 with chronic cerebral ischemia (reduced blood flow to the brain). The goal was to see if it safely improves thinking and memory. Participants had mild to moderate cognitive…
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
Could this drug boost stroke recovery? new trial results are in
Disease control CompletedThis study tested whether adding the drug Mexidol to standard care helps people recover better after a first ischemic stroke. 304 adults who had a stroke within the last 48 hours took either Mexidol or a placebo for about 10 weeks. Researchers measured disability, neurological sy…
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 04:39 UTC
-
Can mexidol help preserve vision in glaucoma patients?
Disease control CompletedThis study tested different doses of the drug Mexidol in 102 adults with moderate to advanced primary open-angle glaucoma. The goal was to see if the drug could improve or protect vision compared to a placebo. Participants received either Mexidol or a placebo over several months,…
Phase: PHASE2 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Can a nerve protector slow glaucoma damage?
Disease control CompletedThis study tested whether a drug called Mexidol can protect the optic nerve in people with advanced primary open-angle glaucoma. Eighty adults with controlled eye pressure took part. The goal was to see if the treatment helps maintain vision and nerve function over time.
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 04:30 UTC